(Q39249440)

10 September 2017

title

Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts (English)

1 reference

10 September 2017

0 references

0 references

0 references

1 reference

5

1 reference

10 September 2017

7

Anders Björklund

0 references

Wolfgang H. Oertel

series ordinal

6

object named as

Wolfgang H Oertel

1 reference

10 September 2017

4

Niall P Quinn

1 reference

10 September 2017

1

Marios Politis

1 reference

10 September 2017

9

Paola Piccini

1 reference

10 September 2017

3

Clare Loane

1 reference

10 September 2017

Kit Wu

2

1 reference

10 September 2017

Olle Lindvall

series ordinal

8

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

Science Translational Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

4

1 reference

10 September 2017

issue

128

1 reference

10 September 2017

page(s)

128ra41

1 reference

Non-motor symptoms of Parkinson's disease: diagnosis and management

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Parkinson's disease symptoms: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Noradrenaline and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonin 2A receptors and visual hallucinations in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonergic mediated body mass index changes in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Sequential bilateral transplantation in Parkinson's disease: effects of the second graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The role of the locus coeruleus in the development of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Aminergic systems in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

The neuropathologic basis of different clinical subgroups of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Serotonin and Parkinson's disease: On movement, mood, and madness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003391

10.1126/SCITRANSLMED.3003391

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference